Please login to the form below

Not currently logged in
Email:
Password:

New deputy commissioner at US FDA

Robert Califf is a vice chancellor at Duke University

Robert Califf, FDAThe US FDA has named a Duke University vice chancellor as deputy commissioner for medical products and tobacco.

In his new role Dr Robert Califf will help lead the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Health and the Center for Tobacco Products at the regulator.

He will also oversee the Office of Special Medical Programs in the Office of the Commissioner when he joins in late February.

FDA commissioner Margaret Hamburg, said: “Dr Califf's deep knowledge and experience in the areas of medicine and clinical research will enable the agency to capitalise on, and improve upon, the significant advances we've made in medical product development and regulation over the last few years.”

Dr Califf is the current vice chancellor of clinical and translational research at Duke University in North Carolina in the US. His previous roles at Duke include director of the Duke Translational Medicine Institute (DTMI) and professor of medicine in the Division of Cardiology. He was also founding director of the Duke Clinical Research Institute.

He has previous experience with the FDA serving as a member of the FDA Cardiorenal Advisory Panel and FDA Science Board's Subcommittee on Science and Technology.

29th January 2015

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics